Genalyte, Inc. a life sciences company developing and commercializing innovative next-generation multiplexing technology. The Company has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids. The Maverick Detection System performs real-time detection of macromolecules in crude samples using biologically functionalized silicon photonic biosensors lithographically printed on disposable silicon chips. These biosensors are individually functionalized with unique probe molecules and are individually interrogated making highly multiplexed analysis possible.

Company Growth (employees)
San Diego, US
Size (employees)
74 (est)+5%
Genalyte was founded in 2007 and is headquartered in San Diego, US

Key People/Management at Genalyte

Cary Gunn

Cary Gunn

President and CEO
Ted Holtaway

Ted Holtaway

Rufus Burlingame

Rufus Burlingame

Vice President of Diagnostic Assay Development
Bradford C. Webb, PhD

Bradford C. Webb, PhD

Member, Board of Directors

Genalyte Office Locations

Genalyte has an office in San Diego
San Diego, US (HQ)
10520 Wateridge Cir

Genalyte Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$91.8 m

Latest funding size

$36 m

Time since last funding

about 1 year


Genalyte's latest funding round in November 2016 was reported to be $36 m. In total, Genalyte has raised $91.8 m

Genalyte's Web-traffic and Trends

Genalyte Online and Social Media Presence

Genalyte Company Life and Culture

You may also be interested in